IL146396A0 - Monoclonal antibody directed against cells of human renal cell carcinoma - Google Patents

Monoclonal antibody directed against cells of human renal cell carcinoma

Info

Publication number
IL146396A0
IL146396A0 IL14639600A IL14639600A IL146396A0 IL 146396 A0 IL146396 A0 IL 146396A0 IL 14639600 A IL14639600 A IL 14639600A IL 14639600 A IL14639600 A IL 14639600A IL 146396 A0 IL146396 A0 IL 146396A0
Authority
IL
Israel
Prior art keywords
monoclonal antibody
renal cell
human renal
cell carcinoma
directed against
Prior art date
Application number
IL14639600A
Other languages
English (en)
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of IL146396A0 publication Critical patent/IL146396A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/106—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from kidney or bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3038—Kidney, bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL14639600A 1999-05-10 2000-05-10 Monoclonal antibody directed against cells of human renal cell carcinoma IL146396A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9905942A FR2793497B1 (fr) 1999-05-10 1999-05-10 Anticorps monoclonal dirige contre les cellules de carcinome renal humain
PCT/FR2000/001258 WO2000067792A1 (fr) 1999-05-10 2000-05-10 Anticorps monoclonal dirige contre les cellules de carcinome renal humain

Publications (1)

Publication Number Publication Date
IL146396A0 true IL146396A0 (en) 2002-07-25

Family

ID=9545417

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14639600A IL146396A0 (en) 1999-05-10 2000-05-10 Monoclonal antibody directed against cells of human renal cell carcinoma
IL146396A IL146396A (en) 1999-05-10 2001-11-08 A monoclonal antibody that targets human kidney cancer cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146396A IL146396A (en) 1999-05-10 2001-11-08 A monoclonal antibody that targets human kidney cancer cells

Country Status (14)

Country Link
US (1) US7074613B1 (de)
EP (1) EP1175227B1 (de)
JP (1) JP2002543811A (de)
AT (1) ATE359091T1 (de)
AU (1) AU781426B2 (de)
CA (1) CA2373631A1 (de)
CY (1) CY1107060T1 (de)
DE (1) DE60034330T2 (de)
DK (1) DK1175227T3 (de)
ES (1) ES2284493T3 (de)
FR (1) FR2793497B1 (de)
IL (2) IL146396A0 (de)
PT (1) PT1175227E (de)
WO (1) WO2000067792A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2793497B1 (fr) 1999-05-10 2003-04-18 Centre Nat Rech Scient Anticorps monoclonal dirige contre les cellules de carcinome renal humain
EP1358318B8 (de) * 2001-02-07 2006-11-15 Wilex AG Hybridomzelllinie g250 und deren verwendung zur herstellung monoklonaler antikörper
US20040077081A1 (en) 2001-02-07 2004-04-22 Egbert Oosterwijk Hybridoma cell line g250 and its use for producing monoclonal antibodies
AU2002367318B2 (en) * 2002-01-02 2007-07-12 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20050074901A1 (en) * 2002-02-13 2005-04-07 John Castracane Methods and assays for detecting and quantifying the human p53 inducible gene protein
AU2003280442B2 (en) 2002-07-01 2009-02-05 Wilex Ag Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
CN111732660B (zh) * 2020-07-31 2020-12-29 河北佑仁生物科技有限公司 骨髓间充质干细胞和单克隆抗体联合治疗癌症

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650756A (en) * 1981-08-31 1987-03-17 Sloan Kettering Institute For Cancer Research Monoclonal antibodies to cell surface antigens of human renal cancer
US4713352A (en) * 1981-08-31 1987-12-15 Sloan-Kettering Institute For Cancer Reseach Monoclonal antibody panel for early diagnosis and therapy of renal carcinoma
EP0119528B1 (de) * 1983-03-11 1992-05-13 Sloan-Kettering Institute For Cancer Research Monoklonale Antikörper gegen menschliche Nierenkrebsantigene und Verfahren
EP0366707A1 (de) * 1987-05-06 1990-05-09 OOSTERWIJK, Egbert Monoklonale antikörper gegen nierenzellen-karzinom
US5145773A (en) 1989-05-25 1992-09-08 Sloan-Kettering Institute For Cancer Research Method to detect sensitivity to alpha-interferon therapy
US5270202A (en) * 1989-11-03 1993-12-14 Syamal Raychaudhuri Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen
US6235280B1 (en) * 1996-04-12 2001-05-22 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
FR2793497B1 (fr) 1999-05-10 2003-04-18 Centre Nat Rech Scient Anticorps monoclonal dirige contre les cellules de carcinome renal humain
US6632431B2 (en) * 2000-05-16 2003-10-14 New York University Anti-idiotypic antibody against FimH adhesion of uropathogenic type I-fimbriated Escherichia coli, compositions containing same and method for using same

Also Published As

Publication number Publication date
EP1175227B1 (de) 2007-04-11
FR2793497B1 (fr) 2003-04-18
WO2000067792A1 (fr) 2000-11-16
AU4415100A (en) 2000-11-21
DK1175227T3 (da) 2007-08-27
IL146396A (en) 2007-06-17
CA2373631A1 (fr) 2000-11-16
DE60034330D1 (de) 2007-05-24
US7074613B1 (en) 2006-07-11
WO2000067792A9 (fr) 2002-09-12
CY1107060T1 (el) 2012-10-24
ATE359091T1 (de) 2007-05-15
ES2284493T3 (es) 2007-11-16
EP1175227A1 (de) 2002-01-30
PT1175227E (pt) 2007-07-18
DE60034330T2 (de) 2007-12-20
AU781426B2 (en) 2005-05-26
FR2793497A1 (fr) 2000-11-17
JP2002543811A (ja) 2002-12-24

Similar Documents

Publication Publication Date Title
CY1107060T1 (el) Μονοκλωνικο αντισωμα κατευθυνομενο κατα των κυτταρων του ανθρωπινου νεφρικου καρκινωματος
NZ337413A (en) Antibodies that bind to Prostate Stem Cell Antigen (PSCA) to treat prostate cancer.
MX9704898A (es) Anticuerpo anti-idiotipo monoclonal murino 3h1.
ZA945364B (en) Antibodies specific for human prostate glandular kallikrein
IS8950A (is) Einklóna mótefni gegn CTLA-4 úr manni.
IL115232A0 (en) Monoclonal antibodies against colon carcinoma-associated antigens
SI1187632T1 (sl) Zdravljenje z anti-ErbB2 protitelesi
HK1074634A1 (en) Internalizing antibodies specific for the raag10 cell surface target
IL139700A0 (en) Immunotherapeutic composition and method for the treatment of prostate cancer
WO2003024191A3 (en) Antibodies that bind to cancer-associated antigen cytokeratin 8 and methods of use thereof
WO1999067384A3 (en) Prostate cancer-associated genes
EP1227159A4 (de) Monoklonaler antikörper, hybridoma, immuntestverfahren und diagnosekit
EP0667529A3 (de) Suppressor von nichtspezifischen Reaktionen in Immuno-Assays.
IL139852A0 (en) Monoclonal antibodies directed against the g3bp protein, and uses
EP0821060A3 (de) E-Cadherin-Mutationen als Grundlage zur Diagnostik und Therapie humaner maligner Tumoren
IL138022A0 (en) High affinity humanized anti-cea monoclonal antibodies
NO974852L (no) Humant <beta>2-integrin-<alfa>-subenhet
WO2000028029A3 (en) Cell surface glycoproteins
WO1992004464A3 (en) Monoclonal antibodies against tenascin
EP0863157B8 (de) Anti-Megakaryozyten monoklonaler Antikörper 97A6
EP1468022A4 (de) Neuer monoklonaler antikörper und antigene gegen nematodenlarven
AU2002326318A1 (en) Targeting tumor cell antigens: antibodies useful for the diagnosis, prognosis, and treatment of cancer
AU4775899A (en) Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cellsand hybridomas for their production
HK1008231A1 (en) Anti-tpo monoclonal antibody.
CA2165672A1 (en) Antibodies specific for human prostate glandular kallikrein

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed